Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients

被引:77
|
作者
Ng, Brendan J. [1 ,2 ,3 ,4 ]
Le Couteur, David G. [1 ,4 ]
Hilmer, Sarah N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Fac Med, Sydney, NSW, Australia
[2] Royal North Shore Hosp, Kolling Inst, Dept Aged Care, St Leonards, NSW, Australia
[3] Royal North Shore Hosp, Kolling Inst, Dept Clin Pharmacol, St Leonards, NSW, Australia
[4] Concord Hosp, Ageing & Alzheimers Inst, Concord, NSW, Australia
关键词
COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM USERS; AGED; 65; YEARS; INAPPROPRIATE BENZODIAZEPINE; GENERAL-PRACTICE; NURSING-HOMES; DOUBLE-BLIND; Z-DRUGS; HOSPITAL INPATIENTS;
D O I
10.1007/s40266-018-0544-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Benzodiazepines (BZDs; including the related Z-drugs) are frequently targets for deprescribing; long-term use in older people is harmful and often not beneficial. BZDs can result in significant harms, including falls, fractures, cognitive impairment, car crashes and a significant financial and legal burden to society. Deprescribing BZDs is problematic due to a complex interaction of drug, patient, physician and systematic barriers, including concern about a potentially distressing but rarely fatal withdrawal syndrome. Multiple studies have trialled interventions to deprescribe BZDs in older people and are discussed in this narrative review. Reported success rates of deprescribing BZD interventions range between 27 and 80%, and this variability can be attributed to heterogeneity of methodological approaches and limited generalisability to cognitively impaired patients. Interventions targeting the patient and/or carer include raising awareness (direct-to-consumer education, minimal interventions, and 'one-off' geriatrician counselling) and resourcing the patient (gradual dose reduction [GDR] with or without cognitive behavioural therapy, teaching relaxation techniques, and sleep hygiene). These are effective if the patient is motivated to cease and is not significantly cognitively impaired. Interventions targeted to physicians include prescribing interventions by audit, algorithm or medication review, and providing supervised GDR in combination with medication substitution. Pharmacists have less frequently been the targets for studies, but have key roles in several multifaceted interventions. Interventions are evaluated according to the Behaviour Change Wheel. Research supports trialling a stepwise approach in the cognitively intact older person, but having a low threshold to use less-consultative methods in patients with dementia. Several resources are available to support deprescribing of BZDs in clinical practice, including online protocols.
引用
收藏
页码:493 / 521
页数:29
相关论文
共 50 条
  • [1] Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients
    Brendan J. Ng
    David G. Le Couteur
    Sarah N. Hilmer
    Drugs & Aging, 2018, 35 : 493 - 521
  • [2] Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians
    Shapoval, Vladyslav
    de Saint Hubert, Marie
    Evrard, Perrine
    Sibille, Francois-Xavier
    Aubert, Carole E.
    Bolt, Lucy
    Tsoutsi, Vagioula
    Kollia, Pinelopi
    Salva, Antoni
    Miralles, Ramon
    Wichniak, Adam
    Gustavsson, Katarzyna
    Wyller, Torgeir Bruun
    Callegari, Enrico
    Grimshaw, Jeremy M.
    Presseau, Justin
    Henrard, Severine
    Spinewine, Anne
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [3] Take a multifaceted stepwise approach when deprescribing benzodiazepines in older patients
    Writers, Adis Medical
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (02) : 72 - 76
  • [5] A tailored outreach program to engage patients and physicians in deprescribing chronic benzodiazepines in primary care
    Chae, S.
    Lindenberg, J.
    Lee, E.
    Shen, K.
    Anderson, T. S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S14 - S15
  • [6] A TAILORED OUTREACH PROGRAM TO ENGAGE PATIENTS AND PHYSICIANS IN DEPRESCRIBING CHRONIC BENZODIAZEPINES IN PRIMARY CARE
    Chae, Sul Gi
    Lindenberg, Julia
    Lee, Emma
    Shen, Kaden
    Anderson, Timothy
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S216 - S217
  • [7] Deprescribing for older patients
    Frank, Christopher
    Weir, Erica
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (18) : 1369 - 1376
  • [8] Impact of Palliative Care Clinical Pharmacists' Deprescribing Efforts in Hospitalized Patients
    Makki, Ibtihal
    Walker, Kathryn A.
    JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2023,
  • [9] Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis
    Zhou, Dan
    Chen, Zhaoyan
    Tian, Fangyuan
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (11) : 1718 - 1725
  • [10] Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials
    Thillainadesan, Janani
    Gnjidic, Danijela
    Green, Sarah
    Hilmer, Sarah N.
    DRUGS & AGING, 2018, 35 (04) : 303 - 319